跳至主要内容
临床试验/CTRI/2018/03/012671
CTRI/2018/03/012671已完成2 期

Efficacy of individualized homoeopathic treatment of hypertension: double blind, randomized placebo controlled clinical trial

ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 个研究点目标入组 68 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients suffering from stage I hypertension (as defined by JNC8 classification, i.e., systolic 140-159 mm Hg or Diastolic 90-99 mm Hg)
  • 2. Age 18-65 years
  • 3. Both sexes
  • 4. New hypertensive patients (those who are accidentally discovered as hypertensive while complaining of some other functional disorders)
  • 5. Patients who have not taken any anti-hypertensive medicine in last week

排除标准

  • 1. Patients who are too sick for consultation
  • 2. Unwilling to take part and not giving consent to join the study
  • 3. Unable to read patient information sheet
  • 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness affecting quality of life or any organ failure
  • 5. Pregnancy and lactation
  • 6. Substance abuse and/or dependence
  • 7. Self-reported immune-compromised state
  • 8. Undergoing homoeopathic treatment for any chronic disease within last 6 months

研究者

发起方
ational Institute of Homoeopathy Ministry of AYUSH Govt of India

相似试验

Homoeopathic treatment of hypertensio | 临床试验